Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
30 results
D1.297 - Clinical characteristics of red meat allergy in 19 cases in Jeju
D1.289 - The buzz that nearly broke a heart: A case of Kounis Syndrome following a Hymenoptera sting
D1.290 - Identification of a Cheese-Derived κ-Casein Fragment as the Trigger of Anaphylaxis in a Patient with Suspected Pasta Allergy
D1.291 - Real-world data of nasal adrenaline spray in anaphylaxis: Review of clinical evidence
D1.292 - Anaphylaxis After Roasted Sunflower Seed Consumption in an Adult: A Case Report
D1.293 - Hidden allergens revealed by prick-to-prick testing: anaphylaxis triggered by black pepper and cumin
D1.295 - Patient Perceived Lifestyle Burden with a Nasal Adrenaline Spray vs an Adrenaline Auto- Injector
D1.296 - Nasal Adrenaline Spray vs Adrenaline Auto-Injectors: When Will People Act?
D1.298 - Does Previous Anaphylaxis Determine Differences between Patients Undergoing Oral Food Challenges to Cow’s Milk and Hen’s Egg?
D1.299 - Lychee-Induced Anaphylaxis: Data from the French Allergy-Vigilance Network since 2002
D1.301 - Non-specific lipid transfer protein allergy: the culprit in disguise
D1.302 - Allergic Reactions Following Measles-Mumps-Rubella Vaccination in Children with Food Allergy: A Single Center Experience
D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects
D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset
D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study
D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)
D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes
D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study
D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria
D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download